Characteristics and prognosis of patients with decompensated right ventricular failure during the course of pulmonary hypertension

Kardiologia Polska

Volumn 66, Issue 10, 2008, Pages 1033-1039

  Kurzyna, Marcin ^a   Zyłkowska, Joanna ^a   Fijałkowska, Anna ^a   Florczyk, Micha ^a   Wieteska, Maria ^a   Kacprzak, Aneta ^a   Burakowski, Janusz ^a   Szturmowicz, Monika ^a   Wawrzyńska, Liliana ^a   Torbicki, Adam ^a  

^a NATIONAL TUBERCULOSIS AND LUNG DISEASES RESEARCH INSTITUTE   (Poland)

Author keywords

Heart failure; Hospitalisation; Mortality; Pulmonary hypertension; Right ventricle; Treatment

Indexed keywords

ANTICOAGULANT AGENT; ASPARTATE AMINOTRANSFERASE; BOSENTAN; DIGITALIS GLYCOSIDE; DIURETIC AGENT; DOPAMINE; ILOPROST; OXYGEN; SILDENAFIL; SITAXSENTAN; UNIPROST;

ADULT; AGED; ARTICLE; CHRONIC DISEASE; CONTROLLED STUDY; DISEASE COURSE; ENZYME ACTIVITY; FEMALE; HEART RIGHT VENTRICLE FAILURE; HEMODYNAMICS; HUMAN; IDIOPATHIC DISEASE; INFECTION; ISCHEMIA; LABORATORY TEST; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; MORTALITY; PATIENT COMPLIANCE; PERIPHERAL CIRCULATION; PROGNOSIS; PULMONARY HYPERTENSION; SURVIVAL; SYSTOLIC BLOOD PRESSURE; VENOUS CONGESTION; VITAL SIGN;

EID: 55049112710     PISSN: 00229032     EISSN: 00229032     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Galiè N, Torbicki A, Barst R, et al. Guidelines on diagnosis and treatment of pulmonary arterial hypertension. The Task Force on Diagnosis and Treatment of Pulmonary Arterial Hypertension of the European Society of Cardiology. Eur Heart J 2004; 25: 2243-78.
2. McLaughlin VV, Presberg KW, Doyle RL, et al. Prognosis of pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines. Chest 2004; 126 (1 Suppl): 78S-92S.
3. Piazza G, Goldhaber SZ. The acutely decompensated right ventricle: pathways for diagnosis and management. Chest 2005; 128: 1836-52.
4. Roguin A, Behar D, Ben Ami H, et al. Long-term prognosis of acute pulmonary oedema-an ominous outcome. Eur J Heart Fail 2000; 2: 137-44.
5. Cleland JG, Swedberg K, Follath F, et al. The EuroHeart Failure survey programme-a survey on the quality of care among patients with heart failure in Europe. Part 1: patient characteristics and diagnosis. Eur Heart J 2003; 24: 442-63.
6. Gheorghiade M, Abraham WT, Albert NM, et al. Systolic blood pressure at admission, clinical characteristics, and outcomes in patients hospitalized with acute heart failure. JAMA 2006; 296: 2217-26.
7. Adams KF Jr, Fonarow GC, Emerman CL, et al. Characteristics and outcomes of patients hospitalized for heart failure in the United States: rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE). Am Heart J 2005; 149: 209-16.
8. Macchia A, Marchioli R, Marfisi R, et al. A meta-analysis of trials of pulmonary hypertension: a clinical condition looking for drugs and research methodology. Am Heart J 2007; 153: 1037-47.
9. Stevenson LW, Massie BM, Francis GS. Optimizing therapy for complex or refractory heart failure: a management algorithm. Am Heart J 1998; 135 (6 Pt 2 Su): S293-S309.
10. Mebazaa A, Gheorghiade M, Piña IL, et al. Practical recommendations for prehospital and early in-hospital management of patients presenting with acute heart failure syndromes. Crit Care Med 2008; 36 (1 Suppl): S129-39.
11. Fijalkowska A, Kurzyna M, Torbicki A, et al. Serum N-terminal brain natriuretic peptide as a prognostic parameter in patients with pulmonary hypertension. Chest 2006; 129: 1313-21.
12. Torbicki A, Kurzyna M, Kuca P, et al. Detectable serum cardiac troponin T as a marker of poor prognosis among patients with chronic precapillary pulmonary hypertension. Circulation 2003; 108: 844-8.
13. Florczyk M, Stawecka-Pawelczyk A, Kurzyna M, et al. Unusual cause of right heart failure decompensation in 21-years old patient with idiopathic pulmonary arterial hypertension - a case report. Pneumonol Alergol Pol 2007; 75: 95-9.
14. Sztrymf B, Bertoletti L, Hamid AM, et al. Survival and prognostic factors of acute exacerbations of pulmonary arterial hypertension. Eur Resp J 2007; 30 (Suppl. 51): 342.
15. Forfia PR, Mathai SC, Fisher MR, et al. Hyponatremia predicts right heart failure and poor survival in pulmonary arterial hypertension. Am J Respir Crit Care Med 2008; 177: 1364-9.
16. Kurzyna M, Da̧browski M, Bielecki D, et al. Atrial septostomy in treatment of end-stage right heart failure in patients with pulmonary hypertension. Chest 2007; 131: 977-83.
17. Abraham WT, Adams KF, Fonarow GC, et al. In-hospital mortality in patients with acute decompensated heart failure requiring intravenous vasoactive medications: an analysis from the Acute Decompensated Heart Failure National Registry (ADHERE). J Am Coll Cardiol 2005; 46: 57-64.
18. Badesch DB, Abman SH, Simonneau G, et al. Medical therapy for pulmonary arterial hypertension: updated ACCP evidence-based clinical practice guidelines. Chest 2007; 131: 1917-28.